Eikon gins up half-a-billion-dollar series B, bolsters C-suite
06 Jan 2022 //
FIERCEBIOTECH
Eikon Therapeutics Appoints Alfred Bowie Jr, PhD as Chief Financial Officer
29 Jun 2021 //
BUSINESSWIRE
06 Jan 2022 //
FIERCEBIOTECH
29 Jun 2021 //
BUSINESSWIRE